Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigation of human regulatory T cell mechanisms of action and suppression assay development

EF 2021-22

Résumé
Regulatory T cells (Tregs) are a specialized type of white blood cell that help maintain a balanced immune system. Tregs can suppress unwanted immune responses, such as those in autoimmunity or in transplant rejection, which has led to the use of Tregs as a cell-based therapy in many immune-related diseases. Tregs can more selectively suppress immune responses, which is a benefit to their use over the commonly used immune-suppressing drugs that broadly suppress the patients immune system and leave them vulnerable to infection. While promising, a limitation to Treg cell therapies is that we do not completely understand how these cells function in humans. Most of our knowledge regarding how Tregs function and the genes involved is based on studies in mice; however, Tregs in mice can function very differently from those in humans. The goal of this project is therefore to develop a better understanding of how human Tregs function to suppress different immune cells. Experiments will use Tregs isolated from male and female thymuses, an organ that contains an abundance of Tregs and that is discarded during heart surgery. I will then use gene-editing technology to delete candidate genes in the isolated thymic Tregs. Gene-deleted Tregs will then be tested for changes in their ability to supress other immune cells, such as B cells and dendritic cells. I will also optimize methods measuring interactions between Tregs and other immune cells. As Tregs hold promise as curative therapies in autoimmunity and transplantation, a better understanding of how Tregs function in humans will help us improve the efficacy of Treg therapies.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466806
Name
Leung Macyn L
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of human regulatory T cell mechanisms of action and suppression assay development
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Assay Development; Cell Therapies; Flow Cytometry; Genome Editing; Regulatory T Cells; Sex-Based Differences; Tolerance Mechanisms
Abstract
Regulatory T cells (Tregs) are a specialized type of white blood cell that help maintain a balanced immune system. Tregs can suppress unwanted immune responses, such as those in autoimmunity or in transplant rejection, which has led to the use of Tregs as a cell-based therapy in many immune-related diseases. Tregs can more selectively suppress immune responses, which is a benefit to their use over the commonly used immune-suppressing drugs that broadly suppress the patients immune system and leave them vulnerable to infection. While promising, a limitation to Treg cell therapies is that we do not completely understand how these cells function in humans. Most of our knowledge regarding how Tregs function and the genes involved is based on studies in mice; however, Tregs in mice can function very differently from those in humans. The goal of this project is therefore to develop a better understanding of how human Tregs function to suppress different immune cells. Experiments will use Tregs isolated from male and female thymuses, an organ that contains an abundance of Tregs and that is discarded during heart surgery. I will then use gene-editing technology to delete candidate genes in the isolated thymic Tregs. Gene-deleted Tregs will then be tested for changes in their ability to supress other immune cells, such as B cells and dendritic cells. I will also optimize methods measuring interactions between Tregs and other immune cells. As Tregs hold promise as curative therapies in autoimmunity and transplantation, a better understanding of how Tregs function in humans will help us improve the efficacy of Treg therapies.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leung, Macyn L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~